Camphor toxicity: Difference between revisions
(camphor background) |
(added reference) |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Common topical agent for pain relief, wart removal, osteoarthritis, cold sores | *Common topical agent for pain relief, wart removal, osteoarthritis, cold sores | ||
*FDA limits over the counter preparations to 11%<ref>United States Food and Drug Administration. Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph. Fed Reg 1983</ref> | |||
*Highly lipophilic, widely and rapidly distributed | *Highly lipophilic, widely and rapidly distributed | ||
==References== | |||
</reference> | |||
Revision as of 01:35, 22 January 2016
Background
- Common topical agent for pain relief, wart removal, osteoarthritis, cold sores
- FDA limits over the counter preparations to 11%[1]
- Highly lipophilic, widely and rapidly distributed
References
</reference>
- ↑ United States Food and Drug Administration. Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph. Fed Reg 1983